Prognostic Value of Biomarkers Associated With Endothelial Progenitor Cells Mobilization in Acute Coronary Syndromes

Assistance Publique Hopitaux De Marseille1 site in 1 country180 target enrollmentJune 2014

ConditionsAcute Coronary Syndromes

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Acute Coronary Syndromes
Sponsor: Assistance Publique Hopitaux De Marseille
Enrollment: 180
Locations: 1
Primary Endpoint: evaluate the value of circulating endothelial progenitor cells quantification in the initial phase of ACS in predicting the occurrence of a major cardiovascular event (ECVM ) at 1 year.
Status: Completed
Last Updated: 7 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

This prospective study aimed to validate a new prognostic approach of endothelial progenitor cells associated biomarkers in patients with acute coronary syndromes . Recruitment is made prospectively by two centers of Inter -region South Mediterranean,

Registry

clinicaltrials.gov

Start Date

June 2014

End Date

August 2018

Last Updated

7 years ago

Study Type

Interventional

Study Design

Single Group

Sex

All

Investigators

Sponsor

Assistance Publique Hopitaux De Marseille

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•acute coronary syndrome (ST + \< 12 hours and ST- high risk or intermediate risk ),which there is an indication of percutaneous coronary intervention.

Exclusion Criteria

•Chronic inflammatory disease
•Infectious disease
•Erythrocyte \<4 G/l
•Thrombopénia less than 100 000/mm3 ;

Outcomes

Primary Outcomes

evaluate the value of circulating endothelial progenitor cells quantification in the initial phase of ACS in predicting the occurrence of a major cardiovascular event (ECVM ) at 1 year.

Time Frame: one year